We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
-1.17%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$890M
AUM Growth
+$199M
Cap. Flow
+$215M
Cap. Flow %
24.19%
Top 10 Hldgs %
22.44%
Holding
152
New
36
Increased
54
Reduced
22
Closed
40

Sector Composition

Rank Sector Weight
1 Healthcare 28.54%
2 Technology 26.69%
3 Industrials 18.66%
4 Consumer Discretionary 7.77%
5 Materials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBR
26
DELISTED
CyberArk
CYBR
$10.4M 1.17%
+61,555
New +$9.34M
CYTK icon
27
Cytokinetics
CYTK
$11B
$9.74M 1.09%
264,698
+45,838
+21% +$1.63M
TBBK icon
28
The Bancorp
TBBK
$2.95B
$9.63M 1.08%
339,945
+47,405
+16% +$1.37M
RBC icon
29
RBC Bearings
RBC
$17.9B
$9.58M 1.08%
49,400
+21,800
+79% +$4.16M
SAIA icon
30
Saia
SAIA
$9.65B
$9.56M 1.07%
39,205
-1,935
-5% -$536K
RPD icon
31
Rapid7
RPD
$694M
$9.53M 1.07%
85,675
-5,985
-7% -$601K
CLH icon
32
Clean Harbors
CLH
$16.2B
$9.46M 1.06%
84,745
+33,725
+66% +$3.33M
MTDR icon
33
Matador Resources
MTDR
$6.04B
$9.45M 1.06%
178,270
+20,095
+13% +$950K
MPWR icon
34
Monolithic Power Systems
MPWR
$66.8B
$9.36M 1.05%
19,270
+15,175
+371% +$6.61M
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.21M 1.03%
87,512
+59,827
+216% +$5.83M
SIBN icon
36
SI-BONE Inc
SIBN
$813M
$9.14M 1.03%
404,527
+280,270
+226% +$5.81M
BHVN
37
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$9.01M 1.01%
75,947
-8,223
-10% -$1.03M
PLNT icon
38
Planet Fitness
PLNT
$4.05B
$8.98M 1.01%
106,313
+18,198
+21% +$1.58M
NARI
39
DELISTED
Inari Medical, Inc. Common Stock
NARI
$8.91M 1%
98,325
+16,865
+21% +$1.38M
PWR icon
40
Quanta Services
PWR
$100B
$8.67M 0.97%
65,906
+34,001
+107% +$3.78M
ENPH icon
41
Enphase Energy
ENPH
$5.24B
$8.48M 0.95%
42,052
+33,182
+374% +$5.21M
EXTR icon
42
Extreme Networks
EXTR
$3.19B
$8.28M 0.93%
678,420
+137,555
+25% +$1.72M
KRNT icon
43
Kornit Digital
KRNT
$772M
$8.27M 0.93%
100,028
-11,145
-10% -$1.08M
AXNX
44
DELISTED
Axonics, Inc. Common Stock
AXNX
$8.16M 0.92%
+130,400
New +$7.03M
CCXI
45
DELISTED
ChemoCentryx, Inc.
CCXI
$8.06M 0.91%
321,569
+90,534
+39% +$2.54M
LFUS icon
46
Littelfuse
LFUS
$11.7B
$7.62M 0.86%
30,531
+20,561
+206% +$5.46M
EWCZ
47
DELISTED
European Wax Center
EWCZ
$7.42M 0.83%
251,200
+110,875
+79% +$2.88M
KNSL icon
48
Kinsale Capital Group
KNSL
$8.57B
$7.33M 0.82%
32,165
+21,145
+192% +$4.41M
SUPN icon
49
Supernus Pharmaceuticals
SUPN
$2.72B
$7.31M 0.82%
226,216
-78,239
-26% -$2.4M
SITE icon
50
SiteOne Landscape Supply
SITE
$4.3B
$7.18M 0.81%
44,397
+23,802
+116% +$4.32M

Similar funds

Lisanti Capital Growth's Q1 2022 Portfolio in Review

As of Q1 2022, Lisanti Capital Growth held 152 positions worth $890M, up 29% from $691M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lisanti Capital Growth deployed $215M of net new capital in Q1 2022, opening 36 new positions and adding to 54 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 278,395 shares worth $17M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Boot Barn, an estimated $6.27M trimmed.

  • Lisanti Capital Growth's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 278,395 shares worth $17M.
  • Lisanti Capital Growth added most to Dave & Buster's in Q1 2022, an estimated $12.9M increase.
  • Lisanti Capital Growth's biggest Q1 2022 reduction was Boot Barn, cutting an estimated $6.27M.
  • Lisanti Capital Growth fully exited Knight Transportation in Q1 2022, selling an estimated $12.1M.
  • Lisanti Capital Growth's ten largest holdings make up 22% of its $890M portfolio in Q1 2022.
  • Lisanti Capital Growth opened 36 new positions and closed 40 in Q1 2022.
  • Lisanti Capital Growth's portfolio value rose 29% quarter-over-quarter to $890M.

Based on Lisanti Capital Growth's 13F filing for Q1 2022, filed 12 May 2022.